Trial Outcomes & Findings for Cervical Cancer Self-Collection for Southeast Asian Immigrant and Refugee Women (NCT NCT05286749)

NCT ID: NCT05286749

Last Updated: 2024-09-19

Results Overview

The results will be reported through summary statistics of the number of participants in each group subsequently engaging or seeking out cervical cancer screening either through services offered after workshop education or self-reported desire to follow up through their community health care provider.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

153 participants

Primary outcome timeframe

up to 1 day

Results posted on

2024-09-19

Participant Flow

Participant milestones

Participant milestones
Measure
Control
Participants take a workshop where they are provided education on standard-of-care for cervical cancer screening such as pap smear and HPV testing through clinician-collection methods using speculum and cervical swabs. Workshop plus Clinician-Collected Cervical Swab: clinician-collection methods using speculum and cervical swabs
Intervention
Participants take a workshop where they are provided all the same education as control as well as additional education on self-collection for HPV-only testing using vaginal swab as an additional method. Workshop plus Participant-Collected Cervical Swab: Evalyn® Brush (Rovers® Medical Devices, Netherlands) HPV testing on Participant-Collected Cervical Swab Samples: Roche Cobas4800 HPV Test System (Roche Molecular Systems Inc., Rotkreuz, Switzerland)
Overall Study
STARTED
75
78
Overall Study
COMPLETED
75
78
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Cervical Cancer Self-Collection for Southeast Asian Immigrant and Refugee Women

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Control
n=75 Participants
Participants take a workshop where they are provided education on standard-of-care for cervical cancer screening such as pap smear and HPV testing through clinician-collection methods using speculum and cervical swabs. Workshop plus Clinician-Collected Cervical Swab: clinician-collection methods using speculum and cervical swabs
Intervention
n=78 Participants
Participants take a workshop where they are provided all the same education as control as well as additional education on self-collection for HPV-only testing using vaginal swab as an additional method. Workshop plus Participant-Collected Cervical Swab: Evalyn® Brush (Rovers® Medical Devices, Netherlands) HPV testing on Participant-Collected Cervical Swab Samples: Roche Cobas4800 HPV Test System (Roche Molecular Systems Inc., Rotkreuz, Switzerland)
Total
n=153 Participants
Total of all reporting groups
Age, Customized
25 to 35 years
26 Participants
n=5 Participants
20 Participants
n=7 Participants
46 Participants
n=5 Participants
Age, Customized
36 to 45 years
19 Participants
n=5 Participants
23 Participants
n=7 Participants
42 Participants
n=5 Participants
Age, Customized
46 to 55 years
15 Participants
n=5 Participants
19 Participants
n=7 Participants
34 Participants
n=5 Participants
Age, Customized
56 to 65 years
15 Participants
n=5 Participants
16 Participants
n=7 Participants
31 Participants
n=5 Participants
Sex: Female, Male
Female
75 Participants
n=5 Participants
78 Participants
n=7 Participants
153 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race/Ethnicity, Customized
Ethnic Group · Burmese
18 Participants
n=5 Participants
19 Participants
n=7 Participants
37 Participants
n=5 Participants
Race/Ethnicity, Customized
Ethnic Group · Hmong
17 Participants
n=5 Participants
18 Participants
n=7 Participants
35 Participants
n=5 Participants
Race/Ethnicity, Customized
Ethnic Group · Karenn
13 Participants
n=5 Participants
15 Participants
n=7 Participants
28 Participants
n=5 Participants
Race/Ethnicity, Customized
Ethnic Group · Karenni
27 Participants
n=5 Participants
26 Participants
n=7 Participants
53 Participants
n=5 Participants
Region of Enrollment
United States
75 participants
n=5 Participants
78 participants
n=7 Participants
153 participants
n=5 Participants
Highest Level of Education
College or Above
10 Participants
n=5 Participants
8 Participants
n=7 Participants
18 Participants
n=5 Participants
Highest Level of Education
High School or Less
27 Participants
n=5 Participants
34 Participants
n=7 Participants
61 Participants
n=5 Participants
Highest Level of Education
None
8 Participants
n=5 Participants
13 Participants
n=7 Participants
21 Participants
n=5 Participants
Highest Level of Education
No Answer
30 Participants
n=5 Participants
23 Participants
n=7 Participants
53 Participants
n=5 Participants
Employment Status
Employed
34 Participants
n=5 Participants
36 Participants
n=7 Participants
70 Participants
n=5 Participants
Employment Status
Unemployed
30 Participants
n=5 Participants
30 Participants
n=7 Participants
60 Participants
n=5 Participants
Employment Status
No Answer
11 Participants
n=5 Participants
12 Participants
n=7 Participants
23 Participants
n=5 Participants
Marital Status
Married
50 Participants
n=5 Participants
48 Participants
n=7 Participants
98 Participants
n=5 Participants
Marital Status
Single
20 Participants
n=5 Participants
16 Participants
n=7 Participants
36 Participants
n=5 Participants
Marital Status
No Answer
5 Participants
n=5 Participants
14 Participants
n=7 Participants
19 Participants
n=5 Participants
Insurance Status
Medicaid
48 Participants
n=5 Participants
42 Participants
n=7 Participants
90 Participants
n=5 Participants
Insurance Status
Medicare
0 Participants
n=5 Participants
3 Participants
n=7 Participants
3 Participants
n=5 Participants
Insurance Status
Private Insurance
18 Participants
n=5 Participants
19 Participants
n=7 Participants
37 Participants
n=5 Participants
Insurance Status
No insurance
9 Participants
n=5 Participants
10 Participants
n=7 Participants
19 Participants
n=5 Participants
Insurance Status
No answer
0 Participants
n=5 Participants
4 Participants
n=7 Participants
4 Participants
n=5 Participants
Birth Country
United States
5 Participants
n=5 Participants
1 Participants
n=7 Participants
6 Participants
n=5 Participants
Birth Country
Outside of the United States
70 Participants
n=5 Participants
77 Participants
n=7 Participants
147 Participants
n=5 Participants
Years Living in the US
5 years or less
8 Participants
n=5 Participants
4 Participants
n=7 Participants
12 Participants
n=5 Participants
Years Living in the US
6 to 10 years
15 Participants
n=5 Participants
21 Participants
n=7 Participants
36 Participants
n=5 Participants
Years Living in the US
11 to 30 years
24 Participants
n=5 Participants
34 Participants
n=7 Participants
58 Participants
n=5 Participants
Years Living in the US
more than 30 years
15 Participants
n=5 Participants
10 Participants
n=7 Participants
25 Participants
n=5 Participants
Years Living in the US
No Answer
13 Participants
n=5 Participants
9 Participants
n=7 Participants
22 Participants
n=5 Participants
Comfort with Written English
Very comfortable
10 Participants
n=5 Participants
5 Participants
n=7 Participants
15 Participants
n=5 Participants
Comfort with Written English
Somewhat comfortable
6 Participants
n=5 Participants
6 Participants
n=7 Participants
12 Participants
n=5 Participants
Comfort with Written English
Neutral
19 Participants
n=5 Participants
19 Participants
n=7 Participants
38 Participants
n=5 Participants
Comfort with Written English
Somewhat uncomfortable
11 Participants
n=5 Participants
14 Participants
n=7 Participants
25 Participants
n=5 Participants
Comfort with Written English
Not at all comfortable
27 Participants
n=5 Participants
32 Participants
n=7 Participants
59 Participants
n=5 Participants
Comfort with Written English
No Answer
2 Participants
n=5 Participants
2 Participants
n=7 Participants
4 Participants
n=5 Participants
Comfort with Oral (heard) English
Very comfortable
9 Participants
n=5 Participants
7 Participants
n=7 Participants
16 Participants
n=5 Participants
Comfort with Oral (heard) English
Somewhat comfortable
9 Participants
n=5 Participants
6 Participants
n=7 Participants
15 Participants
n=5 Participants
Comfort with Oral (heard) English
Neutral
17 Participants
n=5 Participants
16 Participants
n=7 Participants
33 Participants
n=5 Participants
Comfort with Oral (heard) English
Somewhat uncomfortable
13 Participants
n=5 Participants
20 Participants
n=7 Participants
33 Participants
n=5 Participants
Comfort with Oral (heard) English
Not at all comfortable
25 Participants
n=5 Participants
26 Participants
n=7 Participants
51 Participants
n=5 Participants
Comfort with Oral (heard) English
No Answer
2 Participants
n=5 Participants
3 Participants
n=7 Participants
5 Participants
n=5 Participants
Comfort with Written Native Language
Very comfortable
24 Participants
n=5 Participants
29 Participants
n=7 Participants
53 Participants
n=5 Participants
Comfort with Written Native Language
Somewhat comfortable
12 Participants
n=5 Participants
9 Participants
n=7 Participants
21 Participants
n=5 Participants
Comfort with Written Native Language
Neutral
9 Participants
n=5 Participants
11 Participants
n=7 Participants
20 Participants
n=5 Participants
Comfort with Written Native Language
Somewhat uncomfortable
5 Participants
n=5 Participants
6 Participants
n=7 Participants
11 Participants
n=5 Participants
Comfort with Written Native Language
Not at all comfortable
22 Participants
n=5 Participants
19 Participants
n=7 Participants
41 Participants
n=5 Participants
Comfort with Written Native Language
No answer
3 Participants
n=5 Participants
4 Participants
n=7 Participants
7 Participants
n=5 Participants

PRIMARY outcome

Timeframe: up to 1 day

The results will be reported through summary statistics of the number of participants in each group subsequently engaging or seeking out cervical cancer screening either through services offered after workshop education or self-reported desire to follow up through their community health care provider.

Outcome measures

Outcome measures
Measure
Control
n=75 Participants
Participants take a workshop where they are provided education on standard-of-care for cervical cancer screening such as pap smear and HPV testing through clinician-collection methods using speculum and cervical swabs. Workshop plus Clinician-Collected Cervical Swab: clinician-collection methods using speculum and cervical swabs
Intervention
n=78 Participants
Participants take a workshop where they are provided all the same education as control as well as additional education on self-collection for HPV-only testing using vaginal swab as an additional method. Workshop plus Participant-Collected Cervical Swab: Evalyn® Brush (Rovers® Medical Devices, Netherlands) HPV testing on Participant-Collected Cervical Swab Samples: Roche Cobas4800 HPV Test System (Roche Molecular Systems Inc., Rotkreuz, Switzerland)
Number of Participants Who Obtain or Self-Report Future Desire for Cervical Cancer Screening
59 Participants
71 Participants

SECONDARY outcome

Timeframe: up to 1 day (pre workshop and post-workshop, up to 3 hours between surveys)

Participant satisfaction with the educational workshops will be assessed using mixed methods satisfaction surveys. 4-items on the pre- and post-workshop surveys scored on a 5 point likert scale from 1 (not likely) to 5 (very likely) for a total possible range of scores from 1 to 5 where higher scores are a proxy for positive workshop impact on participant. Additional items will include open ended questions on satisfaction.

Outcome measures

Outcome measures
Measure
Control
n=75 Participants
Participants take a workshop where they are provided education on standard-of-care for cervical cancer screening such as pap smear and HPV testing through clinician-collection methods using speculum and cervical swabs. Workshop plus Clinician-Collected Cervical Swab: clinician-collection methods using speculum and cervical swabs
Intervention
n=78 Participants
Participants take a workshop where they are provided all the same education as control as well as additional education on self-collection for HPV-only testing using vaginal swab as an additional method. Workshop plus Participant-Collected Cervical Swab: Evalyn® Brush (Rovers® Medical Devices, Netherlands) HPV testing on Participant-Collected Cervical Swab Samples: Roche Cobas4800 HPV Test System (Roche Molecular Systems Inc., Rotkreuz, Switzerland)
Participant Satisfaction With Educational Workshops Survey Scores
Likelihood to get pap in future
4.6 score on a scale
Standard Deviation 0.854
4.44 score on a scale
Standard Deviation 1.112
Participant Satisfaction With Educational Workshops Survey Scores
Likelihood to spread word about screenings to family/friends
4.76 score on a scale
Standard Deviation 0.654
4.63 score on a scale
Standard Deviation 0.913
Participant Satisfaction With Educational Workshops Survey Scores
Likelihood to encourage your family members to get screened
4.71 score on a scale
Standard Deviation 0.653
4.74 score on a scale
Standard Deviation 0.653
Participant Satisfaction With Educational Workshops Survey Scores
Practice healthy behaviors to reduce risk
4.73 score on a scale
Standard Deviation 0.664
4.88 score on a scale
Standard Deviation 0.394

SECONDARY outcome

Timeframe: up to 1 day

General willingness to use a HPV self-collect device at home and/or as the preferred collection method for cervical cancer screening, assessed via mixed methods survey.

Outcome measures

Outcome measures
Measure
Control
n=75 Participants
Participants take a workshop where they are provided education on standard-of-care for cervical cancer screening such as pap smear and HPV testing through clinician-collection methods using speculum and cervical swabs. Workshop plus Clinician-Collected Cervical Swab: clinician-collection methods using speculum and cervical swabs
Intervention
n=78 Participants
Participants take a workshop where they are provided all the same education as control as well as additional education on self-collection for HPV-only testing using vaginal swab as an additional method. Workshop plus Participant-Collected Cervical Swab: Evalyn® Brush (Rovers® Medical Devices, Netherlands) HPV testing on Participant-Collected Cervical Swab Samples: Roche Cobas4800 HPV Test System (Roche Molecular Systems Inc., Rotkreuz, Switzerland)
Number of Participants Willing to Use HPV Self-collect Device for Their Cervical Cancer Screening
6 Participants
1 Participants

Adverse Events

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Tana Chongsuwat, MD, MPH

UW School of Medicine and Public Health

Phone: 224-260-1666

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place